Thomas Johnston

1.2k total citations
29 papers, 433 citations indexed

About

Thomas Johnston is a scholar working on Surgery, Transplantation and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Thomas Johnston has authored 29 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 10 papers in Transplantation and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Thomas Johnston's work include Renal Transplantation Outcomes and Treatments (10 papers), Organ Transplantation Techniques and Outcomes (5 papers) and Neurological Complications and Syndromes (4 papers). Thomas Johnston is often cited by papers focused on Renal Transplantation Outcomes and Treatments (10 papers), Organ Transplantation Techniques and Outcomes (5 papers) and Neurological Complications and Syndromes (4 papers). Thomas Johnston collaborates with scholars based in United States, Australia and Brazil. Thomas Johnston's co-authors include Carolina Panis, Gazi B. Zibari, Diane M. Cibrik, Rowan G. Walker, Yu Seun Kim, Kevin C. Mange, Qing Xiao, David W. Crabb, Henry Weiner and Dinesh Ranjan and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Scientific Reports.

In The Last Decade

Thomas Johnston

27 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Johnston United States 7 231 156 91 77 74 29 433
W.-D. Illner Germany 13 246 1.1× 243 1.6× 105 1.2× 35 0.5× 68 0.9× 40 542
G. May Germany 12 271 1.2× 179 1.1× 38 0.4× 160 2.1× 42 0.6× 33 542
Kazuharu Uchida Japan 10 241 1.0× 277 1.8× 41 0.5× 40 0.5× 38 0.5× 11 486
M. Franco Brazil 8 211 0.9× 112 0.7× 40 0.4× 34 0.4× 46 0.6× 17 358
Maciej Głyda Poland 12 436 1.9× 218 1.4× 68 0.7× 46 0.6× 131 1.8× 44 602
Kyo M Japan 7 157 0.7× 110 0.7× 27 0.3× 56 0.7× 47 0.6× 26 339
F Oppenheimer Spain 11 154 0.7× 73 0.5× 43 0.5× 50 0.6× 58 0.8× 38 330
Sigrid Bachmann Germany 15 254 1.1× 478 3.1× 26 0.3× 92 1.2× 63 0.9× 18 710
Julio Pascual Spain 9 98 0.4× 80 0.5× 53 0.6× 31 0.4× 22 0.3× 25 301
Marek Myślak Poland 12 298 1.3× 190 1.2× 27 0.3× 67 0.9× 35 0.5× 41 526

Countries citing papers authored by Thomas Johnston

Since Specialization
Citations

This map shows the geographic impact of Thomas Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Johnston more than expected).

Fields of papers citing papers by Thomas Johnston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Johnston. The network helps show where Thomas Johnston may publish in the future.

Co-authorship network of co-authors of Thomas Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Johnston. A scholar is included among the top collaborators of Thomas Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Johnston. Thomas Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pender, Siobhan, Thomas Johnston, YF Liu, et al.. (2025). Ethnicity and socioeconomic status do not influence glycaemic outcomes of a tubeless hybrid closed‐loop system (Omnipod® 5) in adults with type 1 diabetes. Diabetes Obesity and Metabolism. 27(9). 5052–5063.
2.
Valdés, Yudith Ramos, et al.. (2025). CAMKKβ supports growth and viability of epithelial ovarian cancer in vitro and in vivo. Scientific Reports. 15(1). 25913–25913. 1 indexed citations
3.
Reddy, Monika, Parizad Avari, Lalantha Leelarathna, et al.. (2025). Using automated insulin delivery to address the clinical challenges of glycemic management in people with type 1 diabetes and kidney failure on maintenance hemodialysis. Journal of Diabetes Investigation. 16(11). 2027–2032.
4.
Johnston, Thomas, et al.. (2024). Case series of using automated insulin delivery to improve glycaemic control in people with type 1 diabetes and end stage kidney disease on haemodialysis. Diabetes Research and Clinical Practice. 217. 111800–111800. 3 indexed citations
5.
6.
7.
Johnston, Thomas, Jean Ker, Benjie Tang, & Ghulam Nabi. (2012). 1514 LAPAROSCOPIC SURGICAL SKILLS ARE SIGNIFICANTLY IMPROVED BY THE USE OF A PORTABLE LAPAROSCOPIC SIMULATOR RESULTS OF A RANDOMISED CONTROLLED TRIAL. The Journal of Urology. 187(4S). 1 indexed citations
8.
MacLean, Sarah, et al.. (2011). A patient safety ‘Student Selected Component’ at the University of Dundee (UK). Discovery Research Portal (University of Dundee). 5(2). 1 indexed citations
9.
Kim, Young Sam, Hélio Tedesco‐Silva, Thomas Johnston, et al.. (2010). LOWER INCIDENCE OF CYTOMEGALOVIRUS AND BK VIRUS WITH EVEROLIMUS VERSUS MYCOPHENOLATE IN DE NOVO RENAL TRANSPLANT PATIENTS: RESULTS FROM A MULTICENTER, PROSPECTIVE STUDY. Transplantation. 90. 256–256. 6 indexed citations
10.
Tedesco‐Silva, Hélio, Yu Seun Kim, Thomas Johnston, et al.. (2010). EVEROLIMUS WITH REDUCED EXPOSURE OF CYCLOSPORINE: EFFICACY RESULTS FROM A RANDOMIZED PROSPECTIVE STUDY IN 833 DE NOVO RENAL TRANSPLANT RECIPIENTS. Transplantation. 90. 110–110. 5 indexed citations
11.
Cibrik, Diane M., Thomas Johnston, Kevin C. Mange, et al.. (2010). Everolimus Plus Reduced‐Exposure CsA versus Mycophenolic Acid Plus Standard‐Exposure CsA in Renal‐Transplant Recipients. American Journal of Transplantation. 10(6). 1401–1413. 229 indexed citations
12.
Walker, Rowan G., Diane M. Cibrik, Hélio Tedesco‐Silva, et al.. (2010). EVEROLIMUS ALLOWS FOR A 60% REDUCTION IN CYCLOSPORINE EXPOSURE IN SUBJECT COHORTS DEFINED BY GEOGRAPHY. Transplantation. 90. 610–610. 4 indexed citations
13.
Vathsala, Anantharaman, Gazi B. Zibari, Yu Seun Kim, et al.. (2010). DOSE RELATED INCIDENCES OF WOUND HEALING EVENTS IN RENAL TRANSPLANT RECIPIENTS TREATED WITH EVEROLIMUS AND CYCLOSPORINE. Transplantation. 90. 615–615. 4 indexed citations
14.
Turner, et al.. (2007). Analysis of smoking in patients referred for liver transplantation and its adverse impact of short-term outcomes.. PubMed. 105(6). 261–6. 9 indexed citations
15.
Johnston, Thomas, et al.. (2007). A pharmacoeconomic analysis of liver transplant charges. Progress in Transplantation. 17(4). 310–314. 1 indexed citations
16.
Ranjan, Dinesh, et al.. (2005). Financial Analysis of Potential Donor Management at a Medicare-Approved Transplant Hospital. American Journal of Transplantation. 6(1). 199–204. 17 indexed citations
17.
Johnston, Thomas, et al.. (2001). Multiple renal arteries do not pose an impediment to the routine use of laparoscopic donor nephrectomy. Clinical Transplantation. 15(s6). 62–65. 28 indexed citations
18.
Xiao, Qing, Henry Weiner, Thomas Johnston, & David W. Crabb. (1995). The aldehyde dehydrogenase ALDH2*2 allele exhibits dominance over ALDH2*1 in transduced HeLa cells.. Journal of Clinical Investigation. 96(5). 2180–2186. 64 indexed citations
19.
Hromas, Robert, et al.. (1993). Drosophila forkhead homologues are expressed in a lineage-restricted manner in human hematopoietic cells. Blood. 81(11). 2854–2859. 1 indexed citations
20.
Johnston, Thomas. (1980). MORAL EDUCATION FOR NURSING. Nursing Forum. 19(3). 284–299. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W.-D. Illner Breakdown of academic impact, for papers by G. May Breakdown of academic impact, for papers by Kazuharu Uchida Breakdown of academic impact, for papers by M. Franco Breakdown of academic impact, for papers by Maciej Głyda Breakdown of academic impact, for papers by Kyo M Breakdown of academic impact, for papers by F Oppenheimer Breakdown of academic impact, for papers by Sigrid Bachmann Breakdown of academic impact, for papers by Julio Pascual Breakdown of academic impact, for papers by Marek Myślak
Rankless by CCL
2026